检索
AI 对话
AI 辅写
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Treatment with Sofosbuvir and Daclatasvir (with or without Ribavirin) Improves Patient Reported Outcomes in Hepatitis C.

Lucas Pereira Jorge de Medeiros,Mario Barreto Correa Lima,Marcia Maria Amêndola Pires,Alessandra Mendonça Almeida Maciel,Renata Barboza Vianna Medeiros, Mariana Dermínio Donadel, Isabela Martins Becattini Pereira, Fábio Marchon Leão,Luiz Eduardo Amorim Correa Lima Pires, Helio Rzetelna,Carlos Eduardo Brandão-Mello

Osong public health and research perspectives（2018）

引用 5|浏览6
暂无评分
摘要
Treatment with SOF + DCV, with or without RBV, results in an improved PRO similar to treatment with SOF + SMV in chronic hepatitis C patients.
更多
查看译文
关键词
antiviral agents,hepatitis C,patient reported outcome measures,quality of life
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要